TCR2 Therapeutics

Adaptimmune absorbs TCR² to extend cash runway and broaden T-cell pipeline
Fierce Biotech
Mon, 03/6/23 - 11:11 am
Adaptimmune Therapeutics
TCR2 Therapeutics
M&A
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
Wed, 02/1/23 - 10:32 pm
layoffs
Amgen
Merck KGaA
TCR2 Therapeutics
Moderna Therapeutics
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
ESMO
oncology
cancer
Gilead Sciences
Bristol Myers Squibb
Zymeworks
Amgen
Adaptimmune Therapeutics
TCR2 Therapeutics
Boehringer Ingelheim
TCR² releases early data from some PhI patients, sparking optimism from analysts
Endpoints
Mon, 07/27/20 - 11:03 am
TCR2 Therapeutics
clinical trials
t cell therapy
Immuno-Oncology Company Plans $92 Million IPO
CP Wire
Sun, 02/3/19 - 12:53 pm
TCR2 Therapeutics
immuno-oncology
IPOs
Immuno-Oncology Company Plans $92 Million IPO
Sat, 02/2/19 - 03:05 pm
TCR2 Therapeutics
immuno-oncology
IPOs
TCR2 Shoots for $100 Million IPO in Early 2019
BioSpace
Wed, 01/2/19 - 11:41 am
TCR2 Therapeutics
IPOs
CAR-T